CARE Ratings Share Price Rises; Reports 26% Growth in Q2 FY27 Net Profit

CARE Ratings Limited reported a 26% year-on-year increase in consolidated profit after tax (PAT) to ₹72.37 crore in Q2 FY27. The results were disclosed through exchange filings dated October 29, 2026.
Consolidated operating income stood at ₹164.13 crore for the quarter ended September 30, 2026, registering a 20% rise from the year-ago period.
EBITDA increased 23% to ₹84.61 crore. The company reported an EBITDA margin of 52% and a PAT margin of 40%. Consolidated earnings per share (EPS) stood at ₹23.88.
Standalone Financial Results
On a standalone basis, operating income rose 17% to ₹134.21 crore. EBITDA increased 20% to ₹77.99 crore, with the EBITDA margin at 58%.
Standalone PAT grew 24% to ₹69.16 crore compared with Q2 FY26. The PAT margin stood at 46%, while EPS was ₹22.98.
Ratings Business Accounts for Majority of Revenue
The ratings business generated ₹148.51 crore in revenue during the quarter, accounting for the larger share of CARE Ratings' consolidated income. Revenue from this segment increased 21% year-on-year.
The non-ratings business recorded revenue of ₹15.62 crore, up 15% from the corresponding quarter last year.
For the first half of FY27, the ratings business reported revenue of ₹247.22 crore, an increase of 20%. Revenue from the non-ratings business stood at ₹28.59 crore, registering 18% growth.
H1 FY27 Performance
For the six months ended September 30, consolidated operating income increased 20% to ₹275.81 crore. EBITDA rose 24% to ₹119.25 crore, with a margin of 43%.
Consolidated PAT for the period increased 26% to ₹105.36 crore. The PAT margin was 34%, and EPS stood at ₹34.61.
On a standalone basis, H1 operating income reached ₹222.36 crore, up 17%. EBITDA grew 19% to ₹110.09 crore, while PAT increased 21% to ₹103.04 crore.
Interim Dividend
The board declared an interim dividend of ₹10 per share for FY27. The face value of each share is ₹10.
Read More: Voltamp Transformers Share Price in Focus; Reports 42% Revenue Growth in Q2 FY27!
CARE Ratings Share Price Performance
As of October 30, 2026, 11:54 am, CARE Ratings share price was trading at ₹1,641.50, a 1.31% increase from the previous closing price.
Conclusion
For Q2 FY27, CARE Ratings recorded higher operating income and net profit on both standalone and consolidated bases. The board declared an interim dividend of ₹10 per share.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 30, 2026, 12:11 PM IST

Team Angel One
- Deepak Nitrite Share Price Jumps Over 3%; Net Profit Rises 235% in Q2 FY27
- RPG Life Sciences Share Price Crashes Over 10% After Q2 FY27 Results
- ACME Solar Share in Focus as Subsidiary Collaborates with NTPC on 400 MW Renewable Energy Project
- Hikal Share Price Gains Over 8%; Achieves Swissmedic GMP Certification for Bengaluru Facility
- Sun Pharma Share Price Gains Nearly 2%; Secures FDA Approval for ILUMYA in Treating Psoriatic Arthritis




